Tailored MgSO4 Supplementation to Reduce Complications in Pediatric Heart Surgery

Launched by WEST VIRGINIA UNIVERSITY · Aug 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the best way to measure magnesium levels in children's blood after heart surgery. Magnesium is important because it helps reduce the risk of problems with the heart and kidneys, which can happen after surgery. The researchers want to find out if measuring two different forms of magnesium separately—active magnesium and total magnesium—can help doctors give the right amount of magnesium supplement (called MgSO4) to each child. By personalizing the dose based on these measurements, the goal is to better protect the children's heart and kidney function.

To participate in this study, children must be undergoing heart surgery that involves a heart-lung machine, known as cardiopulmonary bypass. However, children with existing kidney disease or heart rhythm issues, or those taking specific medications for these conditions, will not be eligible. Participants can expect to have their heart and kidney health closely monitored after surgery, as researchers will look for any harmful heart rhythms and check how well the kidneys are working. This study aims to improve care for children undergoing heart surgery by ensuring they receive the right magnesium support tailored just for them.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children undergoing cardiac surgery utilizing cardiopulmonary bypass
• Exclusion Criteria:
• • Children undergoing cardiac surgery without cardiopulmonary bypass
• • Children with Renal disease
• • Children with pre-existing arrhythmia
• • Children on anti-arrhythmia medication